Paediatric lymphoma is the third most common childhood malignancy and comprises 15% of childhood cancer and this condition is not only observed in the Paediatric practice in developed countires but ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...
PET/CT scans are crucial for staging, treatment response monitoring, and detecting extramedullary disease in multiple myeloma patients undergoing CAR T-cell therapy. Bone-independent extramedullary ...
We surveyed oncologists who treat classic Hodgkin lymphoma (cHL) as part of the CONNECT study to understand the treatment decision‐making process, including the impact of positron emission ...
When planning cytoreductive surgery for advanced ovarian cancer, clinicians often face uncertainty: Does supradiaphragmatic ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...
NeuroQuant ® PET has received FDA 510(k) clearance (K261916) for PET. NeuroQuant PET ® aids physicians in the evaluation of patient pathologies and the clinical interpretation of PET performed for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results